Diabetes Mellitus, Adult-Onset
14
0
0
9
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 67/100
21.4%
3 terminated out of 14 trials
75.0%
-11.5% vs benchmark
36%
5 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (14)
Technology Intensified Diabetes Education Study in African Americans
Classification of Adult-onset Diabetes in Five Subgroups in Pakistani Population
Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation
Telephone Delivered Behavioral Skills Intervention for Blacks With T2DM
Oleocanthal Rich Olive Oil Acute Effects on Hyperglycemia and Platelet Activation in T2DM
Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood
Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients
Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills
A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy
A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin
A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin
A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 Diabetes
A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled Diet
Early Insulin Treatment in Patients With Latent Autoimmune Diabetes